Substitution of l-Tryptophan by α-Methyl-l-Tryptophan in 177Lu-RM2 Results in 177Lu-AMTG, a High-Affinity Gastrin-Releasing Peptide Receptor Ligand with Improved In Vivo Stability-Reference-Cited by-同舟云学术

Substitution of l-Tryptophan by α-Methyl-l-Tryptophan in ¹⁷⁷Lu-RM2 Results in ¹⁷⁷Lu-AMTG, a High-Affinity Gastrin-Releasing Peptide Receptor Ligand with Improved In Vivo Stability

Published:2022-01-13 Issue:9 Volume:63 Page:1364-1370
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Günther Thomas,Deiser Sandra,Felber Veronika,Beck Roswitha,Wester Hans-Jürgen

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference30 articles.

1. Neuroendocrine tumor therapy with lutetium-177: a literature review;Maqsood;Cureus.,2019

2. PSMA theranostics: current status and future directions;Rahbar;Mol Imaging.,2018

3. Bombesin receptor subtypes in human cancers: detection with the universal radioligand 125I-[D-TYR6, beta-ALA11, PHE13, NLE14] bombesin(6-14);Reubi;Clin Cancer Res.,2002

4. Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting

5. PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiopharmaceuticals Targeting Gastrin-Releasing Peptide Receptor for Diagnosis and Therapy of Prostate Cancer;Molecular Pharmaceutics;2024-08-06

2. Gastrin Releasing Peptide Receptors-targeted PET Diagnostics and Radionuclide Therapy for Prostate Cancer Management;PET Clinics;2024-07

3. Synthesis and Evaluation of Novel 68Ga-Labeled [D-Phe6,Leu13ψThz14]bombesin(6-14) Analogs for Cancer Imaging with Positron Emission Tomography;Pharmaceuticals;2024-05-11

4. Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer;Annals of Medicine;2024-03-05

5. Significant reduction of activity retention in the kidneys via optimized linker sequences in radiohybrid-based minigastrin analogs;EJNMMI Research;2024-03-02